Prostate Cancer Diagnostics Solution Market, Global Outlook and Forecast 2024-2031

Report ID: 1650071 | Published Date: Jan 2025 | No. of Page: 61 | Base Year: 2024 | Rating: 4.3 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Introduction to Research & Analysis Reports
    1.1 Prostate Cancer Diagnostics Solution Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global Prostate Cancer Diagnostics Solution Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global Prostate Cancer Diagnostics Solution Overall Market Size
    2.1 Global Prostate Cancer Diagnostics Solution Market Size: 2021 VS 2028
    2.2 Global Prostate Cancer Diagnostics Solution Market Size, Prospects & Forecasts: 2017-2028
    2.3 Key Market Trends, Opportunity, Drivers and Restraints
        2.3.1 Market Opportunities & Trends
        2.3.2 Market Drivers
        2.3.3 Market Restraints
3 Company Landscape
    3.1 Top Prostate Cancer Diagnostics Solution Players in Global Market
    3.2 Top Global Prostate Cancer Diagnostics Solution Companies Ranked by Revenue
    3.3 Global Prostate Cancer Diagnostics Solution Revenue by Companies
    3.4 Top 3 and Top 5 Prostate Cancer Diagnostics Solution Companies in Global Market, by Revenue in 2021
    3.5 Global Companies Prostate Cancer Diagnostics Solution Product Type
    3.6 Tier 1, Tier 2 and Tier 3 Prostate Cancer Diagnostics Solution Players in Global Market
        3.6.1 List of Global Tier 1 Prostate Cancer Diagnostics Solution Companies
        3.6.2 List of Global Tier 2 and Tier 3 Prostate Cancer Diagnostics Solution Companies
4 Market Sights by Product
    4.1 Overview
        4.1.1 by Type - Global Prostate Cancer Diagnostics Solution Market Size Markets, 2021 & 2028
        4.1.2 Tumor Biomarker Tests
        4.1.3 Imaging
        4.1.4 Biopsy
        4.1.5 Other
    4.2 By Type - Global Prostate Cancer Diagnostics Solution Revenue & Forecasts
        4.2.1 By Type - Global Prostate Cancer Diagnostics Solution Revenue, 2017-2022
        4.2.2 By Type - Global Prostate Cancer Diagnostics Solution Revenue, 2023-2028
        4.2.3 By Type - Global Prostate Cancer Diagnostics Solution Revenue Market Share, 2017-2028
5 Sights by Application
    5.1 Overview
        5.1.1 By Application - Global Prostate Cancer Diagnostics Solution Market Size, 2021 & 2028
        5.1.2 Age Below 55
        5.1.3 Age 55-75
        5.1.4 Age Above 75
    5.2 By Application - Global Prostate Cancer Diagnostics Solution Revenue & Forecasts
        5.2.1 By Application - Global Prostate Cancer Diagnostics Solution Revenue, 2017-2022
        5.2.2 By Application - Global Prostate Cancer Diagnostics Solution Revenue, 2023-2028
        5.2.3 By Application - Global Prostate Cancer Diagnostics Solution Revenue Market Share, 2017-2028
6 Sights by Region
    6.1 By Region - Global Prostate Cancer Diagnostics Solution Market Size, 2021 & 2028
    6.2 By Region - Global Prostate Cancer Diagnostics Solution Revenue & Forecasts
        6.2.1 By Region - Global Prostate Cancer Diagnostics Solution Revenue, 2017-2022
        6.2.2 By Region - Global Prostate Cancer Diagnostics Solution Revenue, 2023-2028
        6.2.3 By Region - Global Prostate Cancer Diagnostics Solution Revenue Market Share, 2017-2028
    6.3 North America
        6.3.1 By Country - North America Prostate Cancer Diagnostics Solution Revenue, 2017-2028
        6.3.2 US Prostate Cancer Diagnostics Solution Market Size, 2017-2028
        6.3.3 Canada Prostate Cancer Diagnostics Solution Market Size, 2017-2028
        6.3.4 Mexico Prostate Cancer Diagnostics Solution Market Size, 2017-2028
    6.4 Europe
        6.4.1 By Country - Europe Prostate Cancer Diagnostics Solution Revenue, 2017-2028
        6.4.2 Germany Prostate Cancer Diagnostics Solution Market Size, 2017-2028
        6.4.3 France Prostate Cancer Diagnostics Solution Market Size, 2017-2028
        6.4.4 U.K. Prostate Cancer Diagnostics Solution Market Size, 2017-2028
        6.4.5 Italy Prostate Cancer Diagnostics Solution Market Size, 2017-2028
        6.4.6 Russia Prostate Cancer Diagnostics Solution Market Size, 2017-2028
        6.4.7 Nordic Countries Prostate Cancer Diagnostics Solution Market Size, 2017-2028
        6.4.8 Benelux Prostate Cancer Diagnostics Solution Market Size, 2017-2028
    6.5 Asia
        6.5.1 By Region - Asia Prostate Cancer Diagnostics Solution Revenue, 2017-2028
        6.5.2 China Prostate Cancer Diagnostics Solution Market Size, 2017-2028
        6.5.3 Japan Prostate Cancer Diagnostics Solution Market Size, 2017-2028
        6.5.4 South Korea Prostate Cancer Diagnostics Solution Market Size, 2017-2028
        6.5.5 Southeast Asia Prostate Cancer Diagnostics Solution Market Size, 2017-2028
        6.5.6 India Prostate Cancer Diagnostics Solution Market Size, 2017-2028
    6.6 South America
        6.6.1 By Country - South America Prostate Cancer Diagnostics Solution Revenue, 2017-2028
        6.6.2 Brazil Prostate Cancer Diagnostics Solution Market Size, 2017-2028
        6.6.3 Argentina Prostate Cancer Diagnostics Solution Market Size, 2017-2028
    6.7 Middle East & Africa
        6.7.1 By Country - Middle East & Africa Prostate Cancer Diagnostics Solution Revenue, 2017-2028
        6.7.2 Turkey Prostate Cancer Diagnostics Solution Market Size, 2017-2028
        6.7.3 Israel Prostate Cancer Diagnostics Solution Market Size, 2017-2028
        6.7.4 Saudi Arabia Prostate Cancer Diagnostics Solution Market Size, 2017-2028
        6.7.5 UAE Prostate Cancer Diagnostics Solution Market Size, 2017-2028
7 Players Profiles
    7.1 OPKO
        7.1.1 OPKO Corporate Summary
        7.1.2 OPKO Business Overview
        7.1.3 OPKO Prostate Cancer Diagnostics Solution Major Product Offerings
        7.1.4 OPKO Prostate Cancer Diagnostics Solution Revenue in Global Market (2017-2022)
        7.1.5 OPKO Key News
    7.2 Genomic Health
        7.2.1 Genomic Health Corporate Summary
        7.2.2 Genomic Health Business Overview
        7.2.3 Genomic Health Prostate Cancer Diagnostics Solution Major Product Offerings
        7.2.4 Genomic Health Prostate Cancer Diagnostics Solution Revenue in Global Market (2017-2022)
        7.2.5 Genomic Health Key News
    7.3 Abbott
        7.3.1 Abbott Corporate Summary
        7.3.2 Abbott Business Overview
        7.3.3 Abbott Prostate Cancer Diagnostics Solution Major Product Offerings
        7.3.4 Abbott Prostate Cancer Diagnostics Solution Revenue in Global Market (2017-2022)
        7.3.5 Abbott Key News
    7.4 Beckman Coulter
        7.4.1 Beckman Coulter Corporate Summary
        7.4.2 Beckman Coulter Business Overview
        7.4.3 Beckman Coulter Prostate Cancer Diagnostics Solution Major Product Offerings
        7.4.4 Beckman Coulter Prostate Cancer Diagnostics Solution Revenue in Global Market (2017-2022)
        7.4.5 Beckman Coulter Key News
    7.5 Siemens Healthcare
        7.5.1 Siemens Healthcare Corporate Summary
        7.5.2 Siemens Healthcare Business Overview
        7.5.3 Siemens Healthcare Prostate Cancer Diagnostics Solution Major Product Offerings
        7.5.4 Siemens Healthcare Prostate Cancer Diagnostics Solution Revenue in Global Market (2017-2022)
        7.5.5 Siemens Healthcare Key News
    7.6 bioMeriux
        7.6.1 bioMeriux Corporate Summary
        7.6.2 bioMeriux Business Overview
        7.6.3 bioMeriux Prostate Cancer Diagnostics Solution Major Product Offerings
        7.6.4 bioMeriux Prostate Cancer Diagnostics Solution Revenue in Global Market (2017-2022)
        7.6.5 bioMeriux Key News
    7.7 Roche
        7.7.1 Roche Corporate Summary
        7.7.2 Roche Business Overview
        7.7.3 Roche Prostate Cancer Diagnostics Solution Major Product Offerings
        7.7.4 Roche Prostate Cancer Diagnostics Solution Revenue in Global Market (2017-2022)
        7.7.5 Roche Key News
    7.8 MDx Health
        7.8.1 MDx Health Corporate Summary
        7.8.2 MDx Health Business Overview
        7.8.3 MDx Health Prostate Cancer Diagnostics Solution Major Product Offerings
        7.8.4 MDx Health Prostate Cancer Diagnostics Solution Revenue in Global Market (2017-2022)
        7.8.5 MDx Health Key News
    7.9 DiaSorin
        7.9.1 DiaSorin Corporate Summary
        7.9.2 DiaSorin Business Overview
        7.9.3 DiaSorin Prostate Cancer Diagnostics Solution Major Product Offerings
        7.9.4 DiaSorin Prostate Cancer Diagnostics Solution Revenue in Global Market (2017-2022)
        7.9.5 DiaSorin Key News
    7.10 Myriad Genetics
        7.10.1 Myriad Genetics Corporate Summary
        7.10.2 Myriad Genetics Business Overview
        7.10.3 Myriad Genetics Prostate Cancer Diagnostics Solution Major Product Offerings
        7.10.4 Myriad Genetics Prostate Cancer Diagnostics Solution Revenue in Global Market (2017-2022)
        7.10.5 Myriad Genetics Key News
    7.11 Ambry Genetics
        7.11.1 Ambry Genetics Corporate Summary
        7.11.2 Ambry Genetics Business Overview
        7.11.3 Ambry Genetics Prostate Cancer Diagnostics Solution Major Product Offerings
        7.11.4 Ambry Genetics Prostate Cancer Diagnostics Solution Revenue in Global Market (2017-2022)
        7.11.5 Ambry Genetics Key News
8 Conclusion
9 Appendix
    9.1 Note
    9.2 Examples of Clients
    9.3 Disclaimer

List of Tables
    Table 1. Prostate Cancer Diagnostics Solution Market Opportunities & Trends in Global Market
    Table 2. Prostate Cancer Diagnostics Solution Market Drivers in Global Market
    Table 3. Prostate Cancer Diagnostics Solution Market Restraints in Global Market
    Table 4. Key Players of Prostate Cancer Diagnostics Solution in Global Market
    Table 5. Top Prostate Cancer Diagnostics Solution Players in Global Market, Ranking by Revenue (2021)
    Table 6. Global Prostate Cancer Diagnostics Solution Revenue by Companies, (US$, Mn), 2017-2022
    Table 7. Global Prostate Cancer Diagnostics Solution Revenue Share by Companies, 2017-2022
    Table 8. Global Companies Prostate Cancer Diagnostics Solution Product Type
    Table 9. List of Global Tier 1 Prostate Cancer Diagnostics Solution Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 10. List of Global Tier 2 and Tier 3 Prostate Cancer Diagnostics Solution Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 11. By Type – Global Prostate Cancer Diagnostics Solution Revenue, (US$, Mn), 2021 & 2028
    Table 12. By Type - Prostate Cancer Diagnostics Solution Revenue in Global (US$, Mn), 2017-2022
    Table 13. By Type - Prostate Cancer Diagnostics Solution Revenue in Global (US$, Mn), 2023-2028
    Table 14. By Application – Global Prostate Cancer Diagnostics Solution Revenue, (US$, Mn), 2021 & 2028
    Table 15. By Application - Prostate Cancer Diagnostics Solution Revenue in Global (US$, Mn), 2017-2022
    Table 16. By Application - Prostate Cancer Diagnostics Solution Revenue in Global (US$, Mn), 2023-2028
    Table 17. By Region – Global Prostate Cancer Diagnostics Solution Revenue, (US$, Mn), 2021 & 2028
    Table 18. By Region - Global Prostate Cancer Diagnostics Solution Revenue (US$, Mn), 2017-2022
    Table 19. By Region - Global Prostate Cancer Diagnostics Solution Revenue (US$, Mn), 2023-2028
    Table 20. By Country - North America Prostate Cancer Diagnostics Solution Revenue, (US$, Mn), 2017-2022
    Table 21. By Country - North America Prostate Cancer Diagnostics Solution Revenue, (US$, Mn), 2023-2028
    Table 22. By Country - Europe Prostate Cancer Diagnostics Solution Revenue, (US$, Mn), 2017-2022
    Table 23. By Country - Europe Prostate Cancer Diagnostics Solution Revenue, (US$, Mn), 2023-2028
    Table 24. By Region - Asia Prostate Cancer Diagnostics Solution Revenue, (US$, Mn), 2017-2022
    Table 25. By Region - Asia Prostate Cancer Diagnostics Solution Revenue, (US$, Mn), 2023-2028
    Table 26. By Country - South America Prostate Cancer Diagnostics Solution Revenue, (US$, Mn), 2017-2022
    Table 27. By Country - South America Prostate Cancer Diagnostics Solution Revenue, (US$, Mn), 2023-2028
    Table 28. By Country - Middle East & Africa Prostate Cancer Diagnostics Solution Revenue, (US$, Mn), 2017-2022
    Table 29. By Country - Middle East & Africa Prostate Cancer Diagnostics Solution Revenue, (US$, Mn), 2023-2028
    Table 30. OPKO Corporate Summary
    Table 31. OPKO Prostate Cancer Diagnostics Solution Product Offerings
    Table 32. OPKO Prostate Cancer Diagnostics Solution Revenue (US$, Mn), (2017-2022)
    Table 33. Genomic Health Corporate Summary
    Table 34. Genomic Health Prostate Cancer Diagnostics Solution Product Offerings
    Table 35. Genomic Health Prostate Cancer Diagnostics Solution Revenue (US$, Mn), (2017-2022)
    Table 36. Abbott Corporate Summary
    Table 37. Abbott Prostate Cancer Diagnostics Solution Product Offerings
    Table 38. Abbott Prostate Cancer Diagnostics Solution Revenue (US$, Mn), (2017-2022)
    Table 39. Beckman Coulter Corporate Summary
    Table 40. Beckman Coulter Prostate Cancer Diagnostics Solution Product Offerings
    Table 41. Beckman Coulter Prostate Cancer Diagnostics Solution Revenue (US$, Mn), (2017-2022)
    Table 42. Siemens Healthcare Corporate Summary
    Table 43. Siemens Healthcare Prostate Cancer Diagnostics Solution Product Offerings
    Table 44. Siemens Healthcare Prostate Cancer Diagnostics Solution Revenue (US$, Mn), (2017-2022)
    Table 45. bioMeriux Corporate Summary
    Table 46. bioMeriux Prostate Cancer Diagnostics Solution Product Offerings
    Table 47. bioMeriux Prostate Cancer Diagnostics Solution Revenue (US$, Mn), (2017-2022)
    Table 48. Roche Corporate Summary
    Table 49. Roche Prostate Cancer Diagnostics Solution Product Offerings
    Table 50. Roche Prostate Cancer Diagnostics Solution Revenue (US$, Mn), (2017-2022)
    Table 51. MDx Health Corporate Summary
    Table 52. MDx Health Prostate Cancer Diagnostics Solution Product Offerings
    Table 53. MDx Health Prostate Cancer Diagnostics Solution Revenue (US$, Mn), (2017-2022)
    Table 54. DiaSorin Corporate Summary
    Table 55. DiaSorin Prostate Cancer Diagnostics Solution Product Offerings
    Table 56. DiaSorin Prostate Cancer Diagnostics Solution Revenue (US$, Mn), (2017-2022)
    Table 57. Myriad Genetics Corporate Summary
    Table 58. Myriad Genetics Prostate Cancer Diagnostics Solution Product Offerings
    Table 59. Myriad Genetics Prostate Cancer Diagnostics Solution Revenue (US$, Mn), (2017-2022)
    Table 60. Ambry Genetics Corporate Summary
    Table 61. Ambry Genetics Prostate Cancer Diagnostics Solution Product Offerings
    Table 62. Ambry Genetics Prostate Cancer Diagnostics Solution Revenue (US$, Mn), (2017-2022)
List of Figures
    Figure 1. Prostate Cancer Diagnostics Solution Segment by Type in 2021
    Figure 2. Prostate Cancer Diagnostics Solution Segment by Application in 2021
    Figure 3. Global Prostate Cancer Diagnostics Solution Market Overview: 2021
    Figure 4. Key Caveats
    Figure 5. Global Prostate Cancer Diagnostics Solution Market Size: 2021 VS 2028 (US$, Mn)
    Figure 6. Global Prostate Cancer Diagnostics Solution Revenue, 2017-2028 (US$, Mn)
    Figure 7. The Top 3 and 5 Players Market Share by Prostate Cancer Diagnostics Solution Revenue in 2021
    Figure 8. By Type - Global Prostate Cancer Diagnostics Solution Revenue Market Share, 2017-2028
    Figure 9. By Application - Global Prostate Cancer Diagnostics Solution Revenue Market Share, 2017-2028
    Figure 10. By Region - Global Prostate Cancer Diagnostics Solution Revenue Market Share, 2017-2028
    Figure 11. By Country - North America Prostate Cancer Diagnostics Solution Revenue Market Share, 2017-2028
    Figure 12. US Prostate Cancer Diagnostics Solution Revenue, (US$, Mn), 2017-2028
    Figure 13. Canada Prostate Cancer Diagnostics Solution Revenue, (US$, Mn), 2017-2028
    Figure 14. Mexico Prostate Cancer Diagnostics Solution Revenue, (US$, Mn), 2017-2028
    Figure 15. By Country - Europe Prostate Cancer Diagnostics Solution Revenue Market Share, 2017-2028
    Figure 16. Germany Prostate Cancer Diagnostics Solution Revenue, (US$, Mn), 2017-2028
    Figure 17. France Prostate Cancer Diagnostics Solution Revenue, (US$, Mn), 2017-2028
    Figure 18. U.K. Prostate Cancer Diagnostics Solution Revenue, (US$, Mn), 2017-2028
    Figure 19. Italy Prostate Cancer Diagnostics Solution Revenue, (US$, Mn), 2017-2028
    Figure 20. Russia Prostate Cancer Diagnostics Solution Revenue, (US$, Mn), 2017-2028
    Figure 21. Nordic Countries Prostate Cancer Diagnostics Solution Revenue, (US$, Mn), 2017-2028
    Figure 22. Benelux Prostate Cancer Diagnostics Solution Revenue, (US$, Mn), 2017-2028
    Figure 23. By Region - Asia Prostate Cancer Diagnostics Solution Revenue Market Share, 2017-2028
    Figure 24. China Prostate Cancer Diagnostics Solution Revenue, (US$, Mn), 2017-2028
    Figure 25. Japan Prostate Cancer Diagnostics Solution Revenue, (US$, Mn), 2017-2028
    Figure 26. South Korea Prostate Cancer Diagnostics Solution Revenue, (US$, Mn), 2017-2028
    Figure 27. Southeast Asia Prostate Cancer Diagnostics Solution Revenue, (US$, Mn), 2017-2028
    Figure 28. India Prostate Cancer Diagnostics Solution Revenue, (US$, Mn), 2017-2028
    Figure 29. By Country - South America Prostate Cancer Diagnostics Solution Revenue Market Share, 2017-2028
    Figure 30. Brazil Prostate Cancer Diagnostics Solution Revenue, (US$, Mn), 2017-2028
    Figure 31. Argentina Prostate Cancer Diagnostics Solution Revenue, (US$, Mn), 2017-2028
    Figure 32. By Country - Middle East & Africa Prostate Cancer Diagnostics Solution Revenue Market Share, 2017-2028
    Figure 33. Turkey Prostate Cancer Diagnostics Solution Revenue, (US$, Mn), 2017-2028
    Figure 34. Israel Prostate Cancer Diagnostics Solution Revenue, (US$, Mn), 2017-2028
    Figure 35. Saudi Arabia Prostate Cancer Diagnostics Solution Revenue, (US$, Mn), 2017-2028
    Figure 36. UAE Prostate Cancer Diagnostics Solution Revenue, (US$, Mn), 2017-2028
    Figure 37. OPKO Prostate Cancer Diagnostics Solution Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 38. Genomic Health Prostate Cancer Diagnostics Solution Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 39. Abbott Prostate Cancer Diagnostics Solution Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 40. Beckman Coulter Prostate Cancer Diagnostics Solution Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 41. Siemens Healthcare Prostate Cancer Diagnostics Solution Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 42. bioMeriux Prostate Cancer Diagnostics Solution Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 43. Roche Prostate Cancer Diagnostics Solution Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 44. MDx Health Prostate Cancer Diagnostics Solution Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 45. DiaSorin Prostate Cancer Diagnostics Solution Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 46. Myriad Genetics Prostate Cancer Diagnostics Solution Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 47. Ambry Genetics Prostate Cancer Diagnostics Solution Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
61
Frequently Asked Questions
Prostate Cancer Diagnostics Solution Market report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Prostate Cancer Diagnostics Solution Market report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Prostate Cancer Diagnostics Solution Market report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Active Dyes Market

This report contains market size and forecasts of Active Dyes in global, including the following  ... Read More